|
Volumn 7, Issue 3, 1989, Pages 171-173
|
Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy: Preliminary communication
a a a |
Author keywords
blood count; Clinical score (Taussig); hospitalization, mortality; pulmonary functions; X ray score (Brasfield Hicks)
|
Indexed keywords
CEFTAZIDIME;
PIPERACILLIN;
TOBRAMYCIN;
ARTICLE;
BLOOD;
CHRONIC DISEASE;
CLINICAL TRIAL;
CYSTIC FIBROSIS;
CYTOLOGY;
DRUG COMBINATION;
DRUG EFFECT;
FORCED EXPIRATORY VOLUME;
GRAM NEGATIVE INFECTION;
HUMAN;
LEUKOCYTE COUNT;
LUNG DISEASE;
NEUTROPHIL;
PSEUDOMONAS AERUGINOSA;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
VITAL CAPACITY;
CEFTAZIDIME;
CHRONIC DISEASE;
CYSTIC FIBROSIS;
DRUG COMBINATIONS;
FORCED EXPIRATORY VOLUME;
HUMAN;
LEUKOCYTE COUNT;
LUNG DISEASES;
NEUTROPHILS;
PIPERACILLIN;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
RANDOM ALLOCATION;
TOBRAMYCIN;
VITAL CAPACITY;
|
EID: 0024351353
PISSN: 87556863
EISSN: 10990496
Source Type: Journal
DOI: 10.1002/ppul.1950070310 Document Type: Article |
Times cited : (15)
|
References (11)
|